Impact of multidisciplinary tumor board discussion on palliation of patients with esophageal or gastro-esophageal junction cancer: a population-based study

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. 15
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–2252.
   PubMed Web of Science ®Google Scholar
• Janmaat VT, Steyerberg EW, van der Gaast A, et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063.
   PubMed Web of Science ®Google Scholar
• Al-Batran SE, Ajani JA. Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer. Cancer. 2010;116(11):2511–2518.
   PubMed Web of Science ®Google Scholar
• van der Bogt RD, Vermeulen BD, Reijm AN, et al. Palliation of dysphagia. Best Pract Res Clin Gastroenterol. 2018;36-37:97–103.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8(2):163–168.
   PubMed Web of Science ®Google Scholar
• Siersema PD, Rosenbrand CJ, Bergman JJ, et al. [Guideline 'Diagnosis and treatment of oesophageal carcinoma']. Ned Tijdschr Geneeskd. 2006;150(34):1877–1882.
   PubMedGoogle Scholar
• Pillay B, Wootten AC, Crowe H, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev. 2016;42:56–72.
   PubMed Web of Science ®Google Scholar
• van Hagen P, Spaander MC, van der Gaast A, et al. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study. Int J Clin Oncol. 2013;18(2):214–219.
   PubMed Web of Science ®Google Scholar
• Walraven JEW, Desar IME, Hoeven van der JJM, et al. Analysis of 105.000 patients with cancer: have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands. Eur J Cancer. 2019;121:85–93.
   PubMed Web of Science ®Google Scholar
• Opstelten JL, de Wijkerslooth LR, Leenders M, et al. Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions. Dis Esophagus. 2017;30(2):1–7.
   PubMed Web of Science ®Google Scholar
• Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–130.
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–1098.
   PubMed Web of Science ®Google Scholar
• Gwynne S, Hurt C, Evans M, et al. Definitive chemoradiation for oesophageal cancer–a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol. 2011;23(3):182–188.
   PubMed Web of Science ®Google Scholar
• Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
   Google Scholar
• Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–1724.
   PubMed Web of Science ®Google Scholar
• Karnofsky DA, Burchenal JH. The clinical evaluation ofchemotherapeutic agents in cancer. In: Macleod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 191–205.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Ogilvie AL, Dronfield MW, Ferguson R, et al. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23(12):1060–1067.
   PubMed Web of Science ®Google Scholar
• van den Boorn HG, Abu-Hanna A, Ter Veer E, et al. SOURCE: a registry-based prediction model for overall survival in patients with metastatic oesophageal or gastric cancer. Cancers (Basel). 2019;11(2):187.
   PubMed Web of Science ®Google Scholar
• MacDermid E, Hooton G, MacDonald M, et al. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis. 2009;11(3):291–295.
   PubMed Web of Science ®Google Scholar
• Bydder S, Nowak A, Marion K, et al. The impact of case discussion at a multidisciplinary team meeting on the treatment and survival of patients with inoperable non-small cell lung cancer. Intern Med J. 2009;39(12):838–841.
   PubMed Web of Science ®Google Scholar
• Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852–2859.
   PubMed Web of Science ®Google Scholar
• Bumm R, Feith M, Lordick F, et al. Impact of multidisciplinary tumor boards on diagnosis and treatment of esophageal cancer. Eur Surg. 2007;39(3):136–140.
   Web of Science ®Google Scholar
• Schmidt HM, Roberts JM, Bodnar AM, et al. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study. Ann Thorac Surg. 2015;99(5):1719–1724.
   PubMed Web of Science ®Google Scholar
• Freeman RK, Van Woerkom JM, Vyverberg A, et al. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer. Ann Thorac Surg. 2011;92(4):1239–1243.
   PubMed Web of Science ®Google Scholar
• Koeter M, van Steenbergen LN, Lemmens VE, et al. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer. Eur J Surg Oncol. 2014;40(10):1338–1345.
   PubMed Web of Science ®Google Scholar
• Amdal CD, Jacobsen AB, Falk RS, et al. Improved treatment decisions in patients with esophageal cancer. Acta Oncol. 2017;56(10):1286–1294.
   PubMed Web of Science ®Google Scholar